Physician profile
Jay P Patel
NPI 1487838249
$3,577.25
in general payments reported to CMS, 2019-2025
14 companies · $667 in 2025
The $667 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $197 · 2021: $156 · 2022: $127 · 2023: $1,411 · 2024: $793 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $886 · Food and Beverage: $730 · Consulting Fee: $730 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $886.39 |
| Food and Beverage | $730.02 |
| Consulting Fee | $730.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,309.42 | 2023 | Cardiomems, Diamondback Peripheral |
| Leica Microsystems INC. | $1,255.00 | 2024-2025 | |
| Philips North America LLC | $254.33 | 2019-2025 | Allura Xper Fd 20 |
| Astrazeneca Pharmaceuticals LP | $145.07 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $124.96 | 2019 | |
| Stryker Corporation | $119.10 | 2023-2025 | Spinejack, Molli |
| Cardiovascular Systems INC. | $107.36 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $107.23 | 2022-2023 | Bard Marquee |
| Hologic Sales and Service, LLC | $43.44 | 2024-2025 | I -View Contrast Enhanced Digital Mammography, Magseed, 3dimensions |
| Abiomed | $41.38 | 2024 | Impella |
| Seagen INC. | $19.35 | 2022 | |
| Agfa Healthcare Corporation | $18.97 | 2025 | |
| Karyopharm Therapeutics INC. | $17.67 | 2022 | |
| Medtronic, INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.